Newsnation
@newsnation·2.7M subscribers·86.7K videos
Wegovy and Zepbound: Which is best for weight loss? | Morning in America
Posted
May 27, 2025
Views
2,903
Likes
34
Comments
8
Engagement
1.45%
May 27, 2025
2,903
34
8
1.45%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
3:04Now PlayingA new study has compared Wegovy and Zepbound head-to-head in their ability to treat obesity. People taking Eli Lilly’s obesity drug Zepbound lost nearly 50% more weight than those using rival Novo Nordisk’s Wegovy. Clinical trial participants who took Zepbound lost an average of 50 pounds over 72 weeks, while those who took Wegovy lost about 33 pounds.
#Zepbound #Wegovy #WeightLoss
Start your day with "Morning in America," NewsNation's live three-hour national morning newscast hosted by Markie Martin. Weekdays starting at 6a/5C. #MorningInAmerica
NewsNation is your source for fact-based, unbiased news for all Americans.
More from NewsNation
Get our app
Find us on cable
How to watch on TV or streaming
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
